Therapeutic review of 23 subependymal giant-cell astrocytoma
- VernacularTitle:23例室管膜下巨细胞星形细胞瘤的治疗评价
- Author:
Lijiang HAN
;
Jizong ZHAO
;
Zhenyu MA
;
Song LIN
;
Yuanli ZHAO
;
Ge YUAN
;
Nan JI
;
Yongji TIAN
;
Tong REN
;
Dong ZHANG
;
Zhenrong SUN
;
Xinru XIAO
;
Kai TANG
;
Mingxue PIAO
;
Xueji LI
;
Hai LIU
;
Xun YE
;
Xiaolin CHEN
- Publication Type:Journal Article
- Keywords: Subependymal giant-cell astreeytoma; Treatment; Estimate; Prognosis
- From: Chinese Journal of Postgraduates of Medicine 2009;32(23):18-21
- CountryChina
- Language:Chinese
- Abstract: Objective To analyze and estimate, the treatment of patients with histologically confirmed subependymal giant-cell astroeytoma (SEGCA). Methods The data from 23 patients with SEG-CA who were diagnosed between February 1995 and February 2008 were retrospectively evaluated. Various combinations of surgery and radiotherapy had been used for treatment. Results Total resection was 16 cases, subtotal resection was 7 cases, radiotherapy was 17 cases. The average follow-up time was 53 months.One postoperative SEGCA recurrence. Epilepsy was totally disappeared in 17.6% (3/17), partly disappeared in 47.1%(8/17). All cases survived. Conclusions The key of treatment is total resection. The significance of radiotherapy is not sure. The overall prognosis of SEGCA is favorable.